Singapore's National Dental Research Institute Launches Global Oral Diseases Consortium

National Dental Centre Singapore’s research arm, the National Dental Research Institute Singapore (NDRIS) has established an international collaborat...

July 26, 2023 | Wednesday | News
DuoPharma Biotech to scale screening device iBreastExam across Malaysia

Malaysia’s leading pharmaceutical company, Duopharma Biotech Berhad (“Duopharma Biotech”) through its wholly-owned subsidiary, Duopharma ...

July 25, 2023 | Tuesday | News
Lupin Emphasizes In-Home Cardiovascular Care with Digital Therapeutics

India based Lupin Digital Health and the American College of Cardiology (ACC) have announced a first-of-its-kind collaboration to deliver in-home cardiovas...

July 25, 2023 | Tuesday | News
AstraZeneca's Dapagliflozin Receives Expanded Approval for Heart Failure Treatment in India

AstraZeneca Pharma India has received extended indication approval from the Drugs Controller General of India (DCGI) for its drug, Dapagliflozin in the tre...

July 25, 2023 | Tuesday | News
Molecule AI Harnesses AI Power to Tackle Medicine's Toughest Challenges

What if there was a solution? A golden key or antidote to lift the fog and restore your mind? How far would you go to obtain it? And if it doesn't ...

July 24, 2023 | Monday | News
HUTCHMED's Fruquintinib Combo Receives Breakthrough Designation in China for Advanced Endometrial Cancer, Enrollment Complete

It is a multi-center, open-label clinical study to evaluate the efficacy and safety of fruquintinib in combination with sintilimab. Entry criteria include ...

July 20, 2023 | Thursday | News
Junshi Biosciences' Toripalimab Accepted for First-line Treatment of Extensive-stage Small Cell Lung Cancer

According to data released by GLOBOCAN 2020, lung cancer is currently the most prevalent malignant tumor with the highest mortality rate in China. Small ce...

July 20, 2023 | Thursday | News
Yikaida CAR-T Cell Therapy Approved as a Second-line Therapy for New Indication

Previously, there was no CAR-T cell therapy product in China for the treatment of adult large B-cell lymphoma who failed to respond to first-line immunoche...

July 19, 2023 | Wednesday | News
Samsung Biologics releases 2023 ESG Report, reaffirming its commitment to net-zero progress and corporate social responsibility

“Samsung Biologics is fully committed to engaging in sustainable business practices for the positive impact it has on our clients, society, and the w...

July 18, 2023 | Tuesday | News
Japan's ThinkCyte & FIMM Forge Research Partnership to Fight Blood Cancer

"Blood cancers are a complex, heterogeneous set of diseases and while the treatment landscape has advanced in recent years, there is still a lot we don't k...

July 18, 2023 | Tuesday | News
Examining the Biopharma Industry's Declining Resilience: Factors, Vulnerabilities, and Strategies for Growth

Join us for an in-depth conversation with Chua Keng Hock as we explore the challenges, strategies, and future prospects of the biopharma industry in today'...

July 18, 2023 | Tuesday | Interaction
InnoCare and ArriVent Announce Clinical Development Collaboration

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases and ArriVent Bi...

July 14, 2023 | Friday | News
Merck Invests € 23 Million to Expand Cell Culture Media Production in Kansas, USA

Lenexa, Kansas, USA facility becomes company’s largest dry powder cell culture media facility and Center of Excellence  in North America Boos...

July 13, 2023 | Thursday | News
Avantor® Inaugurates Expanded Singapore Hub

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies, a...

July 13, 2023 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close